These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31887053)

  • 1. Understanding the Effects of a Polymer on the Surface Dissolution of Pharmaceutical Cocrystals Using Combined Experimental and Molecular Dynamics Simulation Approaches.
    Kirubakaran P; Wang K; Rosbottom I; Cross RBM; Li M
    Mol Pharm; 2020 Feb; 17(2):517-529. PubMed ID: 31887053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into Flufenamic Acid Cocrystal Dissolution in the Presence of a Polymer in Solution: from Single Crystal to Powder Dissolution.
    Guo M; Wang K; Qiao N; Fábián L; Sadiq G; Li M
    Mol Pharm; 2017 Dec; 14(12):4583-4596. PubMed ID: 29091446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating Permeation Behavior of Flufenamic Acid Cocrystals Using a Dissolution and Permeation System.
    Guo M; Wang K; Qiao N; Yardley V; Li M
    Mol Pharm; 2018 Sep; 15(9):4257-4272. PubMed ID: 30080976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimisation of Pharmaceutical Cocrystal Dissolution Performance through a Synergistic Precipitation Inhibition.
    Shi K; Li M
    Pharm Res; 2023 Aug; 40(8):2051-2069. PubMed ID: 37188904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the Influence of Polymers on Supersaturated Flufenamic Acid Cocrystal Solutions.
    Guo M; Wang K; Hamill N; Lorimer K; Li M
    Mol Pharm; 2016 Sep; 13(9):3292-307. PubMed ID: 27494289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the polymer matrix in solvent-free hot melt extrusion continuous process for mechanochemical synthesis of pharmaceutical cocrystal.
    Gajda M; Nartowski KP; Pluta J; Karolewicz B
    Eur J Pharm Biopharm; 2018 Oct; 131():48-59. PubMed ID: 30205892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expedited Tablet Formulation Development of a Highly Soluble Carbamazepine Cocrystal Enabled by Precipitation Inhibition in Diffusion Layer.
    Yamashita H; Sun CC
    Pharm Res; 2019 Apr; 36(6):90. PubMed ID: 31016440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Influence of Various Polymers on Dissolution and Phase Behavior of Carbamazepine-Succinic Acid Cocrystal in Matrix Tablets.
    Ullah M; Ullah H; Murtaza G; Mahmood Q; Hussain I
    Biomed Res Int; 2015; 2015():870656. PubMed ID: 26380301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
    Qiao N; Wang K; Schlindwein W; Davies A; Li M
    Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Polymers on Cocrystal Growth in a Drug-Drug Coamorphous System: Relations between Glass-to-Crystal Growth and Surface-Enhanced Crystal Growth.
    Luo M; Chen A; Huang C; Guo M; Cai T
    Mol Pharm; 2024 Jul; 21(7):3591-3602. PubMed ID: 38818946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Coformer and Polymer on Particle Surface Solution-Mediated Phase Transformation of Cocrystals in Aqueous Media.
    Omori M; Watanabe T; Uekusa T; Oki J; Inoue D; Sugano K
    Mol Pharm; 2020 Oct; 17(10):3825-3836. PubMed ID: 32870691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution Profiles of Carbamazepine Cocrystals with Cis-Trans Isomeric Coformers.
    Omori M; Yamamoto H; Matsui F; Sugano K
    Pharm Res; 2023 Feb; 40(2):579-591. PubMed ID: 35194718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial neural networks (ANNs) and partial least squares (PLS) regression in the quantitative analysis of cocrystal formulations by Raman and ATR-FTIR spectroscopy.
    Barmpalexis P; Karagianni A; Nikolakakis I; Kachrimanis K
    J Pharm Biomed Anal; 2018 Sep; 158():214-224. PubMed ID: 29886369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion.
    Boksa K; Otte A; Pinal R
    J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of coformers on phase transformation and release profiles of carbamazepine cocrystals in hydroxypropyl methylcellulose based matrix tablets.
    Qiu S; Li M
    Int J Pharm; 2015 Feb; 479(1):118-28. PubMed ID: 25542989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion.
    Liu X; Lu M; Guo Z; Huang L; Feng X; Wu C
    Pharm Res; 2012 Mar; 29(3):806-17. PubMed ID: 22009589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: a case study using olanzapine.
    Pina MF; Zhao M; Pinto JF; Sousa JJ; Craig DQ
    J Pharm Sci; 2014 Apr; 103(4):1214-23. PubMed ID: 24765654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of different polymers on crystallization tendency and dissolution behavior of cilnidipine in solid dispersions.
    Chen C; Xie X; Li Y; Zhou C; Song Y; Yan Z; Yang X
    Drug Dev Ind Pharm; 2014 Apr; 40(4):441-51. PubMed ID: 23614831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial dissolution kinetics of cocrystal of carbamazepine with nicotinamide.
    Hattori Y; Sato M; Otsuka M
    J Pharm Pharmacol; 2015 Nov; 67(11):1512-8. PubMed ID: 26285918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the effect of hydroxypropyl methylcellulose on the phase transformation and release profiles of carbamazepine-nicotinamide cocrystal.
    Li M; Qiu S; Lu Y; Wang K; Lai X; Rehan M
    Pharm Res; 2014 Sep; 31(9):2312-25. PubMed ID: 24590881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.